Brian W. Brannigan

21.7k total citations · 5 hit papers
25 papers, 15.4k citations indexed

About

Brian W. Brannigan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Brian W. Brannigan has authored 25 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Brian W. Brannigan's work include Lung Cancer Treatments and Mutations (10 papers), Cancer Cells and Metastasis (8 papers) and HER2/EGFR in Cancer Research (6 papers). Brian W. Brannigan is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cancer Cells and Metastasis (8 papers) and HER2/EGFR in Cancer Research (6 papers). Brian W. Brannigan collaborates with scholars based in United States, South Korea and Italy. Brian W. Brannigan's co-authors include Daniel A. Haber, Daphne W. Bell, Thomas J. Lynch, Ross A. Okimoto, Raffaella Sordella, Patricia L. Harris, Jeff Settleman, Sara M. Haserlat, David C. Christiani and David N. Louis and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Brian W. Brannigan

25 papers receiving 15.0k citations

Hit Papers

Activating Mutations in the Epidermal Growth Factor Recep... 2004 2026 2011 2018 2004 2014 2008 2005 2005 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
    2004 8.9k citations Thomas J. Lynch, Daphne W. Bell et al. New England Journal of Medicine profile →
  2. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
    2014 1.8k citations Nicola Aceto, Aditya Bardia et al. Cell profile →
  3. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
    2008 1.3k citations Shyamala Maheswaran, Lecia V. Sequist et al. New England Journal of Medicine profile →
  4. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
    2005 774 citations Eunice L. Kwak, Raffaella Sordella et al. Proceedings of the National Academy of Sciences profile →
  5. Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials
    2005 518 citations Daphne W. Bell, Thomas J. Lynch et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian W. Brannigan United States 18 9.5k 9.1k 6.0k 4.3k 858 25 15.4k
Jeff Settleman United States 38 10.8k 1.1× 8.5k 0.9× 10.6k 1.8× 5.1k 1.2× 1.5k 1.7× 66 20.5k
Raffaella Sordella United States 26 8.0k 0.8× 8.6k 0.9× 6.9k 1.1× 3.0k 0.7× 934 1.1× 33 14.8k
Naiyer A. Rizvi United States 61 11.0k 1.2× 7.7k 0.8× 3.5k 0.6× 2.2k 0.5× 773 0.9× 275 15.0k
Nicola Normanno Italy 63 10.5k 1.1× 5.6k 0.6× 8.4k 1.4× 4.5k 1.1× 2.2k 2.6× 362 18.5k
Amita Patnaik United States 62 8.4k 0.9× 4.5k 0.5× 6.2k 1.0× 2.1k 0.5× 1.2k 1.4× 365 14.4k
Toyoaki Hida Japan 61 8.1k 0.8× 8.5k 0.9× 4.0k 0.7× 2.0k 0.5× 583 0.7× 280 13.4k
Cloud P. Paweletz United States 50 4.0k 0.4× 4.6k 0.5× 5.5k 0.9× 3.9k 0.9× 1.1k 1.3× 136 10.8k
Anthony W. Tolcher United States 62 7.2k 0.8× 3.7k 0.4× 8.8k 1.5× 2.3k 0.5× 1.6k 1.8× 438 16.5k
Alice T. Shaw United States 74 15.9k 1.7× 18.5k 2.0× 9.7k 1.6× 5.9k 1.4× 2.3k 2.7× 332 25.2k
Melinda E. Sanders United States 45 6.5k 0.7× 2.5k 0.3× 6.0k 1.0× 4.8k 1.1× 1.2k 1.4× 119 13.3k

Countries citing papers authored by Brian W. Brannigan

Since Specialization
Citations

This map shows the geographic impact of Brian W. Brannigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian W. Brannigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian W. Brannigan more than expected).

Fields of papers citing papers by Brian W. Brannigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian W. Brannigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian W. Brannigan. The network helps show where Brian W. Brannigan may publish in the future.

Co-authorship network of co-authors of Brian W. Brannigan

This figure shows the co-authorship network connecting the top 25 collaborators of Brian W. Brannigan. A scholar is included among the top collaborators of Brian W. Brannigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian W. Brannigan. Brian W. Brannigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyamoto, David T., Yu Zheng, Ben S. Wittner, et al.. (2015). Single Cell RNA Profiling of Circulating Tumor Cells in Patients With Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S104–S104. 2 indexed citations
2.
Aceto, Nicola, Aditya Bardia, David T. Miyamoto, et al.. (2014). Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis. Cell. 158(5). 1110–1122. 1786 indexed citations breakdown →
3.
Luo, Xi, Devarati Mitra, Ryan J. Sullivan, et al.. (2014). Abstract 4832: Isolation and molecular characterization of circulating melanoma cells. Cancer Research. 74(19_Supplement). 4832–4832. 1 indexed citations
4.
Ting, David T., Ben S. Wittner, Ajay M. Shah, et al.. (2014). Abstract NG04: Diversity of circulating tumor cells in a mouse pancreatic cancer model identified by single cell RNA sequencing. Cancer Research. 74(19_Supplement). NG04–NG04. 2 indexed citations
5.
Luo, Xi, Devarati Mitra, Ryan J. Sullivan, et al.. (2014). Isolation and Molecular Characterization of Circulating Melanoma Cells. Cell Reports. 7(3). 645–653. 79 indexed citations
6.
Miyamoto, David T., Richard J. Lee, Shannon L. Stott, et al.. (2012). Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer. Cancer Discovery. 2(11). 995–1003. 217 indexed citations
7.
Ozsolak, Fatih, David T. Ting, Ben S. Wittner, et al.. (2010). Amplification-free digital gene expression profiling from minute cell quantities. Nature Methods. 7(8). 619–621. 42 indexed citations
8.
Zhang, Jianmin, Young‐Han Song, Brian W. Brannigan, et al.. (2009). Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin. Molecular Cancer Research. 7(9). 1510–1516. 12 indexed citations
9.
McDermott, Ultan, A. John Iafrate, Shyamala Maheswaran, et al.. (2009). Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors. Cancer Research. 69(9). 3937–3946. 83 indexed citations
10.
Bell, Daphne W., Brian W. Brannigan, Keitaro Matsuo, et al.. (2008). Increased Prevalence ofEGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms. Clinical Cancer Research. 14(13). 4079–4084. 64 indexed citations
11.
Maheswaran, Shyamala, Lecia V. Sequist, Sunitha Nagrath, et al.. (2008). Detection of Mutations in EGFR in Circulating Lung-Cancer Cells. New England Journal of Medicine. 359(4). 366–377. 1295 indexed citations breakdown →
12.
Zampa, G., et al.. (2008). Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinib. Lung Cancer. 60(3). 452–454. 10 indexed citations
13.
Rivera, Miguel N., Woo‐Jae Kim, Julie Wells, et al.. (2007). An X Chromosome Gene, WTX , Is Commonly Inactivated in Wilms Tumor. Science. 315(5812). 642–645. 225 indexed citations
14.
Kwak, Eunice L., Janusz Jankowski, Sarah P. Thayer, et al.. (2006). Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas. Clinical Cancer Research. 12(14). 4283–4287. 133 indexed citations
15.
Kwak, Eunice L., Raffaella Sordella, Daphne W. Bell, et al.. (2005). Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proceedings of the National Academy of Sciences. 102(21). 7665–7670. 774 indexed citations breakdown →
16.
Bell, Daphne W., Thomas J. Lynch, Sara M. Haserlat, et al.. (2005). Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials. Journal of Clinical Oncology. 23(31). 8081–8092. 518 indexed citations breakdown →
17.
Bell, Daphne W., Ira Gore, Ross A. Okimoto, et al.. (2005). Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nature Genetics. 37(12). 1315–1316. 380 indexed citations
18.
Cohen, Ezra E.W., Mark W. Lingen, Leslie E. Martin, et al.. (2005). Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation ofERBB2rather thanEGFR. Clinical Cancer Research. 11(22). 8105–8108. 104 indexed citations
19.
Lynch, Thomas J., Daphne W. Bell, Raffaella Sordella, et al.. (2004). Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib. New England Journal of Medicine. 350(21). 2129–2139. 8906 indexed citations breakdown →
20.
Jefferies, P.R., Robert F. Toia, Brian W. Brannigan, Isaac N. Pessah, & John E. Casida. (1992). Ryania insecticide: analysis and biological activity of 10 natural ryanoids. Journal of Agricultural and Food Chemistry. 40(1). 142–146. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeff Settleman Breakdown of academic impact, for papers by Raffaella Sordella Breakdown of academic impact, for papers by Naiyer A. Rizvi Breakdown of academic impact, for papers by Nicola Normanno Breakdown of academic impact, for papers by Amita Patnaik Breakdown of academic impact, for papers by Toyoaki Hida Breakdown of academic impact, for papers by Cloud P. Paweletz Breakdown of academic impact, for papers by Anthony W. Tolcher Breakdown of academic impact, for papers by Alice T. Shaw Breakdown of academic impact, for papers by Melinda E. Sanders
Rankless by CCL
2026